Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
about
Protein phosphatase 1alpha is a Ras-activated Bad phosphatase that regulates interleukin-2 deprivation-induced apoptosisThe p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathwayThe Ca2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 actionMechanisms of noise-induced hearing loss indicate multiple methods of prevention.Pentoxifylline sensitizes human cervical tumor cells to cisplatin-induced apoptosis by suppressing NF-kappa B and decreased cell senescence.TRAIL/Apo-2L: mechanisms and clinical applications in cancer.Differential regulation of calcium homeostasis in adenocarcinoma cell line A549 and its Taxol-resistant subcloneLoss of Fas-ligand expression in mouse keratinocytes during UV carcinogenesisSensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.Protein kinase A type II-α regulatory subunit regulates the response of prostate cancer cells to taxane treatment.Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy.Matrix attachment regulates Fas-induced apoptosis in endothelial cells: a role for c-flip and implications for anoikisAccumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model.The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.TRPC6 channel activation promotes neonatal glomerular mesangial cell apoptosis via calcineurin/NFAT and FasL/Fas signaling pathways.Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor.Regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by reversible phosphorylation and dephosphorylation.Advanced glycation end products (AGEs) induce apoptosis via a novel pathway: involvement of Ca2+ mediated by interleukin-8 protein.Docetaxel induces Bcl-2- and pro-apoptotic caspase-independent death of human prostate cancer DU145 cells.Short-term exposure to oleandrin enhances responses to IL-8 by increasing cell surface IL-8 receptors.Disruption of the interaction between PMCA2 and calcineurin triggers apoptosis and enhances paclitaxel-induced cytotoxicity in breast cancer cells.Cryptotanshinone induces ER stress-mediated apoptosis in HepG2 and MCF7 cells.A novel AP-1 element in the CD95 ligand promoter is required for induction of apoptosis in hepatocellular carcinoma cells upon treatment with anticancer drugs.Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma.Nuclear translocation and activation of the transcription factor NFAT is blocked by herpes simplex virus infection.The rare-earth yttrium complex [YR(mtbmp)(thf)] triggers apoptosis via the extrinsic pathway and overcomes multiple drug resistance in leukemic cells.Late phase activation of nuclear transcription factor kappaB by doxorubicin is mediated by interleukin-8 and induction of apoptosis via FasL.Stimulatory heterotrimeric GTP-binding protein inhibits hydrogen peroxide-induced apoptosis by repressing BAK induction in SH-SY5Y human neuroblastoma cells.Cardiac glycoside induces cell death via FasL by activating calcineurin and NF-AT, but apoptosis initially proceeds through activation of caspases.Apoptosis of non-small-cell lung cancer cell lines after paclitaxel treatment involves the BH3-only proapoptotic protein Bim.Dephosphorylation of Bcl-2 by protein phosphatase 2A results in apoptosis resistance.A conserved calcineurin-binding motif in human T lymphotropic virus type 1 p12I functions to modulate nuclear factor of activated T cell activation.Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes.Synergistic Bcl-2 inhibition by ABT-737 and cyclosporine A.Fas-dependent tissue turnover is implicated in tumor cell clearance.Inhibition of transcription factor activity by nuclear compartment-associated Bcl-2.Hypericin photo-induced apoptosis involves the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and activation of caspase-8.Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.Integrin signaling inhibits paclitaxel-induced apoptosis in breast cancer cells.Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
P2860
Q24594034-FCF7A473-053E-4D3E-82D6-D4766543B43FQ28252683-134796EA-7DCB-4834-BDCE-EA88C4C188DDQ28366131-9030BD7C-1067-4566-B7D5-EDF2799C17E8Q30500834-28BCFFA6-09BF-4511-9E3A-74961A194320Q34072134-E01BD8E9-E742-42C5-A50E-8687938F4E44Q34482821-2126F2ED-E30D-4637-AFAF-68AB508506BCQ35047122-970D22FE-6C03-427A-8304-A1F4418C162EQ35829735-353F1E15-94A3-49B7-893F-F166FCE4E927Q36059686-41CA7CCB-9660-4381-B049-C3FA874BA210Q36188433-F9EC81C9-3CC2-425A-8225-4E4D1936C338Q36375843-BA1AE465-EC04-4299-81F6-529068EB7534Q36376466-EED92121-30C6-4C68-9CC2-2AA578BA4BDDQ36412928-C7DE9D64-0ABD-46AC-B4E5-9CB73C4BB5C2Q36779438-80E61176-62CE-486B-BEA5-05C8550E43A3Q37072696-0A836942-3EF7-4062-9987-9EE4AF83BBE3Q37341230-113488C8-0221-4623-A1A7-FEBFBB2DE255Q37365504-004BD5C4-8059-4530-A984-47E033625580Q38621503-49A57F4E-72F7-4EC9-BE02-1D8017D2B3D7Q38777929-AAEDFBEC-A84D-4E2E-94D0-597BEA9ADE51Q39068821-2B8BC587-4F40-41F4-A4D8-ABE4955080EAQ39282391-246F86F4-6B76-4E19-AC86-6809C76224D7Q39437850-5F8772ED-D405-4C44-BE01-D42784940CF8Q39456231-A83ACF3A-B516-4537-8E9C-8E4897A4A564Q39525572-A121FAAE-BDE6-4AB0-9F68-7E8024505046Q39604496-B09BDEAE-4387-4854-A402-38B8932EC716Q39614493-52B59E96-8C08-49CF-864F-EAF1DC0C4121Q39817767-CD7491E0-88E4-476A-84CD-561E078FC6D8Q40054434-43A6B5F5-97E6-46EF-B37D-11577468EFF4Q40186826-EB2B8E5B-BE4A-4355-B586-89433096B316Q40458245-334639F7-4A51-4020-A60A-57FBE1CABFB5Q40579498-9F281445-C2BA-4AA1-9284-FA420CDF2B49Q40668711-0203CE30-9294-43DA-80AD-7DC47078D4D9Q40761200-28392702-619E-4D3F-93FE-EE44077FDF1CQ42517322-24B567BF-34E6-4DF7-8883-D483573DDF01Q42802931-F331E570-8A07-4B99-A353-370800217A12Q42824791-2575D1C0-A90C-448E-BC3C-84640C3A9154Q43559012-39C37BA1-FF33-4A33-9088-AB15F37F7158Q43680908-2CFB1CAD-6488-4E03-98A1-DBF618AF6EEFQ43722430-1E77BD80-E15B-483F-B0EC-F0C242D2D619Q43761459-37C2CB2F-6401-4F1E-8DDF-6FBD25A2B45A
P2860
Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@ast
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@en
type
label
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@ast
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@en
prefLabel
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@ast
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@en
P2093
P2860
P356
P1476
Bcl-2-mediated drug resistance ...... uced Fas ligand transcription.
@en
P2093
C Y Sasaki
J M Hardwick
R K Srivastava
P2860
P304
P356
10.1084/JEM.190.2.253
P407
P577
1999-07-01T00:00:00Z